Teva Pharmaceuticals announced the availability of Norethindrone Acetate (NA) and Ethinyl Estradiol (EE) Tablets and Ferrous Fumarate (Fe) Tablets 1mg/20mcg, the authorized generic for Minastrin 24 Fe.
This estrogen/progestin combination oral contraceptive is indicated for use by women to prevent pregnancy. The efficacy of NA/EE and Fe in women with a body mass index (BMI) of more than 35kg/m2 has not been evaluated.
Combination oral contraceptives lower the risk of becoming pregnant primarily by suppressing ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.
The product is available in blister cards containing 28 tablets (24 active tablets containing 1mg of NA and 20mcg of EE and 4 non-hormonal placebo pills containing 75mg of Fe). The Fe tablets do not serve any therapeutic purpose.
For more information visit TevaPharm.com.